This data sheet describes SafePatient ECG, Clario’s centralized alert service designed to optimize patient enrollment and minimize cardiac risk in late-phase clinical trials. Screening and on-study ECGs are rapidly analyzed by expert cardiologists, often within four hours, supporting accurate inclusion and exclusion decisions while patients are still onsite. Centralization reduces variability from site-managed devices, decreases false inclusions and exclusions, and enhances patient safety. The service provides real-time analytics, global logistics support, and seamless system integration, helping sponsors accelerate timelines, maintain budget certainty, and ensure regulatory-quality cardiac safety oversight.

Join for free to read